Clinical Trial Update: CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating CPX-351 (Vyxeos) or CLAG-M regimen for acute myeloid leukemia or other high-grade myeloid neoplasms in medically less…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myeloid Neoplasms

Drugs mentioned

• CLAG-M regimen
• CPX-351 (Vyxeos) (CPX-351)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Acute Myeloid Leukemia, Myeloid Neoplasm | Phase 2 | Status: ACTIVE_NOT_RECRUITING